Transforming growth factor beta-1, galectin 3 and left atrium fibrosis in patients with paroxysmal atrial fibrillation and metabolic syndrome

被引:0
|
作者
Zaslavskaya, E. [1 ]
Morozov, A. N. [1 ]
Ionin, V. A. [1 ]
Biryukov, A. V. [1 ]
I, M. A. [1 ]
Nifontov, S. E. [1 ]
Baranova, E. I. [2 ]
Yashin, S. M. [1 ]
Shlyakhto, E. V. [1 ]
机构
[1] St Petersburg Pavlov State Med Univ, St Petersburg, Russia
[2] Fed Almazov Med Res Ctr, St Petersburg, Russia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P2878
引用
收藏
页码:603 / 604
页数:2
相关论文
共 50 条
  • [21] Clinical Impact of Cryoballoon Ablation for Paroxysmal Atrial Fibrillation in Patients With Enlarged Left Atrium
    Ukita, Kohei
    Egami, Yasuyuki
    Nohara, Hiroaki
    Kawanami, Shodai
    Kawamura, Akito
    Yasumoto, Koji
    Tsuda, Masaki
    Okamoto, Naotaka
    Matsunaga-Lee, Yasuharu
    Yano, Masamichi
    Nishino, Masami
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 208 : 111 - 115
  • [22] MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation
    Wang, Jiangang
    Song, Shiqiu
    Xie, Changqing
    Han, Jie
    Li, Yan
    Shi, Jiahai
    Xin, Meng
    Wang, Jun
    Luo, Tiange
    Meng, Xu
    Yang, Bo
    BMC CARDIOVASCULAR DISORDERS, 2015, 15
  • [23] Serum Galectin-3 Level Predicts the Extent of Left Atrial Fibrosis in Lone Atrial Fibrillation Patients
    Gurses, Kadri M.
    Yalcin, Muhammed U.
    Kocyigit, Duygu
    Canpinar, Hande
    Canpolat, Ugur
    Evranos, Banu
    Yorgun, Hikmet
    Sahiner, Mehmet L.
    Kaya, Ergun B.
    Guc, Dicle
    Oto, Mehmet A.
    Aytemir, Kudret
    CIRCULATION, 2014, 130
  • [24] Transforming growth factor beta-1 (TGF-β1) expression in patients with adenomyosis
    Jacobo, Andreia
    Borges, Renata Fogaca
    de Souza, Carlos Augusto Bastos
    Genro, Vanessa Krebs
    Cunha-Filho, Joao Sabino
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2024, 46
  • [25] Thioacetamide-induced hepatic fibrosis in transforming growth factor beta-1 transgenic mice
    Schnur, J
    Oláh, J
    Szepesi, A
    Nagy, P
    Thorgeirsson, SS
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (02) : 127 - 133
  • [26] Metabolic syndrome and risk of transition to chronic atrial fibrillation in patients with nonvalvular paroxysmal atrial fibrillation
    Sakabe, K.
    Fukuda, N.
    Fukuda, Y.
    Morishita, S.
    Shinohara, H.
    Tamura, Y.
    EUROPEAN HEART JOURNAL, 2009, 30 : 657 - 658
  • [27] Relationship between epicardial fat and left atrium fibrosis in patients with atrial fibrillation
    Nascimento Matos, D.
    Ferreira, A.
    Freitas, P.
    Rodrigues, G.
    Carmo, J.
    Carvalho, M. S.
    Abecasis, J.
    Carmo, P.
    Saraiva, C.
    Cavaco, D.
    Morgado, F.
    Mendes, M.
    Adragao, P.
    EUROPEAN HEART JOURNAL, 2020, 41 : 588 - 588
  • [28] LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway
    Wu, Yingbiao
    Can, Jin
    Hao, Shuwen
    Qiang, Xun
    Ning, Zhongping
    CEREBROVASCULAR DISEASES, 2022, 51 (02) : 188 - 198
  • [29] Epicardial Adipose Tissue Around the Left Atrium is Associated With Atrial Fibrosis in Patients With Atrial Fibrillation
    Askari-Atapour, Bahareh
    Kwan, Kristen
    Anderson, Carter A.
    Jafarvand, Mahbod
    Birjandian, Zeinab
    Tregoning, Deanna
    Boyle, Patrick M.
    Akoum, Nazem W.
    CIRCULATION, 2021, 144
  • [30] Transforming growth factor beta-1 level in pleural effusion
    Ceyhan, BB
    Demiralp, E
    Karakurt, ZL
    Karakurt, S
    Sungur, M
    RESPIROLOGY, 2003, 8 (03) : 321 - 325